Drug Pricing and Affordable Insulin Issues Take Precedence

Action on drug pricing and access to affordable insulin has heated up in Congress as part of the consideration of a large budget reconciliation process. The Endocrine Society has been a leading advocate urging the Biden Administration and Congress to take action on drug pricing and has offered several policy recommendations, including allowing the government […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:

Share this article